VistaGen Therapeutics Inc...

NASDAQ: VTGN · Real-Time Price · USD
3.17
-0.23 (-6.76%)
At close: Aug 19, 2025, 3:59 PM
3.20
0.95%
After-hours: Aug 19, 2025, 04:12 PM EDT

VistaGen Therapeutics Revenue

VistaGen Therapeutics reported an annual revenue of $486K, reflecting a -54.32% growth. For the quarter ending June 30, 2025, VistaGen Therapeutics generated $244K in revenue.
Revenue (ttm)
486K
Revenue Growth
-54.32%
Price / Sales Ratio
157.98
Revenue / Employee
10.13K
Employees
48
Market Cap
97.26M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Mar 31, 2025 486K -54.32%
Mar 31, 2024 1.06M +-568.72%
Mar 31, 2023 -227K -120.47%
Mar 31, 2022 1.11M +1.78%
Mar 31, 2021 1.09M +Infinity%
Mar 31, 2020 0 n/a
Mar 31, 2019 0 n/a
Mar 31, 2018 0 -100.00%
Mar 31, 2017 1.25M +Infinity%
Mar 31, 2016 0 n/a
Mar 31, 2015 0 n/a
Mar 31, 2014 0 -100.00%
Mar 31, 2013 200.4K -85.07%
Mar 31, 2012 1.34M +Infinity%
Dec 31, 2010 0 n/a
Dec 31, 2009 0 n/a
Dec 31, 2008 0 n/a
Dec 31, 2007 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.